Showing results (71-80 of 4,451) with videos related to
Sort By:
Pageof 446
Gastroenterology|June 14, 2022
METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal CancerHuarong Chen, Yasi Pan, Qiming Zhou, et al.Oncogene|July 29, 2018
CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesisWeilin Li, Chi Chun Wong, Xiaoming Zhang, et al.Cell Reports. Medicine|August 16, 2023
METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapyYasi Pan, Huarong Chen, Xiang Zhang, et al.Cancer Discovery|April 27, 2025
Intra-hepatic microbial heterogeneity in multifocal hepatocellular carcinoma and its association with host genomic and transcriptomic alterationsYinghong Lu, Lixia Xu, Weikang Chen, et al.Science Translational Medicine|April 20, 2018
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical targetDabin Liu, Chi Chun Wong, Li Fu, et al.Signal Transduction and Targeted Therapy|December 21, 2025
YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancerHenley Cheung, Huarong Chen, Danyu Chen, et al.Journal of Agricultural and Food Chemistry|March 23, 2011
First chemical synthesis and in vitro characterization of the potential human metabolites 5-o-feruloylquinic acid 4'-sulfate and 4'-O-glucuronideCandice Menozzi-Smarrito, Chi Chun Wong, Walter Meinl, et al.Gastroenterology|May 11, 2023
ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting ImmunotherapyJianning Zhai, Huarong Chen, Chi Chun Wong, et al.Oncogene|April 22, 2020
AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesisYuhang Zhou, Jinglin Zhang, Hui Li, et al.Nature Communications|December 14, 2025
Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancerHeming Zhou, Huarong Chen, Weixin Liu, et al.Pageof 446